Retrospect and prospect of virtual screening in drug discovery
Xu, H.
Current Topics in Medicinal Chemistry 2(12): 1305-1320
2002
ISSN/ISBN: 1568-0266 PMID: 12470282 Document Number: 541229
We review the prominent technologies in virtual screening, and their applications in drug discovery.
Document emailed within 1 workday
Related Documents
Muchmore, S.W.; Hajduk, P.J. 2003: Crystallography, NMR and virtual screening: integrated tools for drug discovery Current Opinion in Drug Discovery and Development 6(4): 544-549Jain, A.N. 2004: Virtual screening in lead discovery and optimization Current Opinion in Drug Discovery and Development 7(4): 396-403
Langer, T.; Krovat, E.Maria. 2003: Chemical feature-based pharmacophores and virtual library screening for discovery of new leads Current Opinion in Drug Discovery and Development 6(3): 370-376
Raha, M.K. 1991: Polyandry in India: retrospect and prospect Man in India 71(1): 163-181
He, X.; Zeng, D. 2004: Applied ecology: retrospect and prospect Ying Yong Sheng Tai Xue Bao 15(10): 1691-1697
Voigt, H.; Katzschmann, R.; Bürger, M. 1986: Diabetic angiopathy--retrospect and prospect Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 41(20): 580-582
Makinodan, T. 1977: Biology of aging: retrospect and prospect Comprehensive Immunology 1977(1): 1-7
Yamaguchi, N. 2000: Retrospect and prospect of the Japanese Society of Neuropsychiatry Seishin Shinkeigaku Zasshi 102(8): 675-683
Wu, C. 1987: Asia's population and development in retrospect and prospect China Population Newsletter 4(5): 3-6
Wang, H. 1992: Cellular and molecular biology: prospect and retrospect Zhonghua Yi Xue Za Zhi 72(4): 193-194
Xia, S.S. 1992: Organ transplantation in China: retrospect and prospect Chinese Medical Journal 105(5): 430-432
Sagawa, K. 1984: End-systolic pressure-volume relationship in retrospect and prospect Federation Proceedings 43(9): 2399-2401
Yang, J.M.; Watson, W.B. 1973: Family planning and fertility decline in Korea: retrospect and prospect International Journal of Health Services: Planning Administration Evaluation 3(4): 821-832
Zartler, E.R.; Shapiro, M.J. 2006: Protein NMR-based screening in drug discovery Current Pharmaceutical Design 12(31): 3963-3972
Spetea, M.; Asim, M.Faheem.; Noha, S.; Wolber, G.; Schmidhammer, H. 2013: Current κ opioid receptor ligands and discovery of a new molecular scaffold as a κ opioid receptor antagonist using pharmacophore-based virtual screening Current Pharmaceutical Design 19(42): 7362-7372
Hu, H-yu. 2002: NMR-based screening of protein inhibitors in drug discovery Yao Xue Xue Bao 37(2): 158-160
Golz, S.; Jörg Hüser 2007: Discovery of a New Drug - From Target Identification to Ultra-High-Throughput Screening Clinical Laboratory 53(1-2): 77-79
Jacoby, E.; Davies, J.; Blommers, M.J.J. 2003: Design of small molecule libraries for NMR screening and other applications in drug discovery Current Topics in Medicinal Chemistry 3(1): 11-23
Kojima, H.; Okabe, T.; Nagano, T. 2013: Open innovation center for drug discovery: a research-supporting network for drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(6): 327-332
Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95